- Home
- SKY vs PTGX Comparison
SKY vs PTGX Comparison
Compare SKY & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKY | PTGX |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 5.4B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | SKY | PTGX |
|---|---|---|
| Price | $85.39 | $89.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $85.00 | ★ $86.44 |
| AVG Volume (30 Days) | 640.4K | ★ 898.7K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.48 | N/A |
| EPS | ★ 3.84 | 0.72 |
| Revenue | ★ $2,624,539,000.00 | $209,217,000.00 |
| Revenue This Year | $7.67 | N/A |
| Revenue Next Year | $4.67 | $296.47 |
| P/E Ratio | ★ $22.25 | $124.48 |
| Revenue Growth | ★ 12.14 | N/A |
| 52 Week Low | $59.44 | $33.70 |
| 52 Week High | $116.49 | $93.25 |
Technical Indicators
Market Signals| Indicator | SKY | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 61.66 | 64.67 |
| Support Level | $83.25 | $83.52 |
| Resistance Level | $87.17 | $90.85 |
| Average True Range (ATR) | 2.76 | 2.63 |
| MACD | 0.08 | -0.33 |
| Stochastic Oscillator | 81.63 | 83.62 |
Price Performance
Historical ComparisonAbout SKY Skyline Champion Corporation
Champion Homes Inc is a factory-built housing company in North America. The company is well positioned with an portfolio of manufactured and modular homes, ADUs, park-models and modular buildings for the single-family, multi-family, and other hospitality sectors. In addition to its core home building business, the company provides construction services to install and set-up factory-built homes, operates a factory-direct retail business with 72 retail locations across the United States, and operates Star Fleet Trucking, providing transportation services to the manufactured housing and other industries from several dispatch locations across the United States.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.